Trial Profile
A study of Ipragliflozin and Phentermine in obese perimenopausal and menopausal women for weight control
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2017
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary) ; Phentermine (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 24 Nov 2017 New trial record
- 14 Oct 2017 Preliminary results presented at the North American Menopause Society 2017 Annual Meeting